PERSPECTA

News from every angle

Back to headlines

Moderna and Merck's Melanoma Vaccine Shows Success in Large Trial; FIT Hailed for Colorectal Cancer

Moderna and Merck have announced a breakthrough in personalized cancer vaccines, with their melanoma vaccine succeeding in a large trial. Separately, the Faecal Immunochemical Test (FIT) has been hailed as a 'game changer' in the fight against colorectal cancer in western Jamaica.

19 Aug, 05:07 — 19 Aug, 05:07
PostShare